Zydus receives final approval for Temozolomide Capsules
From USFDA
Zydus Cadila has received final approval from USFDA to market Temozolomide Capsules in strengths of 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg. Temozolomide capsule is a chemotheraphy drug used in the management of brain tumors.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 01 2017 | 11:32 AM IST